These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 513651)

  • 21. Influence of sulphone therapy on lepromin reaction.
    Ramu G; Sengupta U; Desikan KV
    Lepr Rev; 1980 Sep; 51(3):207-14. PubMed ID: 7442412
    [No Abstract]   [Full Text] [Related]  

  • 22. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
    Jain VK; Verma KC; Aggarwal SS
    Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dapsone induced hypohaptoglobinemia in lepromatous leprosy patients.
    Sritharan V; Bharadwaj VP; Venkatesan K; Girdhar BK
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):307-10. PubMed ID: 7198620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
    Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lucio's phenomenon and diffuse nonnodular lepromatous leprosy.
    Rea TH; Levan NE
    Arch Dermatol; 1978 Jul; 114(7):1023-8. PubMed ID: 686719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of blood ascorbic acid in leprosy.
    Sinha SN; Gupta SC; Bajaj AK; Singh PA; Kumar P
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):159-62. PubMed ID: 6539308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
    Gupta N; Shankernarayan NP; Dharmalingam K
    J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral zinc as an adjunct to dapsone in lepromatous leprosy.
    Mathur NK; Bumb RA; Mangal HN; Sharma ML
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):331-8. PubMed ID: 6541200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leprosy XII. Quantitative analysis of thymus-derived lymphocyte response to phytohemagglutinin in leprosy.
    Lim SD; Jacobson RR; Park BH; Good RA
    Int J Lepr Other Mycobact Dis; 1975; 43(2):95-100. PubMed ID: 1081499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dapsone resistant leprosy, the western Kenya experience.
    Orege PA; Owili DM
    Trop Geogr Med; 1985 Jun; 37(2):139-42. PubMed ID: 4035777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clofazimine and dapsone--a combination therapy in erythema nodosum leprosum syndrome.
    Dutta RK
    Lepr India; 1980 Apr; 52(2):252-9. PubMed ID: 7453140
    [No Abstract]   [Full Text] [Related]  

  • 37. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK; Jacobson RR; Hastings RC
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone.
    Kulkarni VM; Mishra DS
    Indian J Lepr; 1985; 57(4):756-62. PubMed ID: 3835207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea.
    Cellona RV; Fajardo TT; Kim DI; Hah YM; Ramasoota T; Sampattavanich S; Carrillo MP; Abalos RM; dela Cruz EC; Ito T
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):1-11. PubMed ID: 2181040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
    Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
    Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.